Ulcerative colitis (UC) is a chronic disease of the colon or large intestine that causes inflammation and ulceration of the inner lining of the colon and rectum. In patients with ulcerative colitis, the body’s immune system overreacts and the body mistakes food, bacteria or other internal materials in the colon for an invading substance. The immune system attacks the material, thus irritating the colon. Limited knowledge of inflammatory conditions coupled with a narrow range of therapeutic options necessitates investigating the role of natural products. This study describes the effect of natural coconut oil on chemically-induced acute and chronic disease in mice. Ulcerative colitis was induced in four groups (5 mice per group) of 10-week-old female C57BL/6 mice by exposing them to 2.5-3% dextran sulfate sodium (DSS) for 5 and 29 days in the acute and chronic models, respectively. Coconut oil treatment was given via food containing 5% coconut oil to three diseased groups in three different regimens: one, preventive group receiving treatment prior to disease induction (14 d in acute; 28 d in chronic); two, simultaneous group receiving treatment simultaneous to disease induction; and three, regular treatment group receiving treatment after the disease induction –until termination of the experiment (14 d in acute; 60 d in chronic). Coconut food was replaced by the regular chow in the disease and water control groups. Clinical symptoms (diarrhea, occult blood, anal bleeding and body weight change) and the size of the isolated colon were recorded for comparison between experimental and control groups. Groups receiving coconut food displayed remissions in clinical markers of the disease. Improvements in clinical symptoms, histopathology, as well as cytokine activities were observed in both models, but the effects were more significant on the basis of standard error in the chronic model.

This research used a focused ion beam in order to fabricate record small nano-magnetic structures, investigate the properties of magnetic materials in the rarely studied range of nanometer size, and exploit their extraordinary characteristics in medicine and nano-electronics. This study consists of two parts: (i) Fabrication and study of record small magnetic tunnel junctions (ii) Introduction of a novel method for detection of magnetoelectric nanoparticles (MENs) in the tissue. A key challenge in further scaling of CMOS devices is being able to perform non-volatile logic with near zero power consumption. Sub-10-nm nanomagnetic spin transfer torque (STT) magnetic tunneling junctions (MTJs) have the potential for a universal memory that can address this key challenge. The main problem is to decrease the switching current density. This research studied these structures in sub-10-nm size range. In this range, spin related excitations consume considerably smaller amounts of energy as compared to the larger scale. This research concluded that as predicted a decrease in switching current superior to that of the linear scaling will happen in this size range. Magneto-electric nanoparticles (MENs) can be used to directly couple intrinsic electric-field-driven processes with external magnetic fields for controlling neural activity deep in the brain. These particles have been proven to be capable of inducing deep brain stimulation non-invasively. Furthermore, these magneto-electric nano-particles can be used for targeted drug delivery and are contenders to replace conventional chemotherapy. The circulatory system can deliver a drug to almost every cell in the body; however, delivering the drug specifically into the tumor cell and then releasing it on demand remains a formidable task. Nanomedicine can accomplish this, but ensuring that the drug is released at an appropriate rate once at the target site is an important task. In order to have a complete understanding of the behavior of these MENs when injected into the body, a comprehensive bio-distribution study was performed. This study introduced a novel spectroscopy method for tracing the nanoparticles in the bloodstream. This study investigated the post injection distribution of the MENs in vital organs throughout a period of two months.

A febre reumática é uma das sequelas da infecção causada por Streptococcus pyogenes, afetando notadamente crianças e jovens, com altas taxas de morbidade e mortalidade em várias regiões do mundo, incluindo Brasil. Perfis imunoquímicos desenvolvidos por antígenos celulares e extracelulares desta bactéria e isotipos de anticorpos presentes em pacientes com febre reumática foram averiguados, em virtude da escassez de informação a este respeito na literatura. Na primeira fase do trabalho, as condições para o preparo de antígenos, bem como de técnicas, em especial a técnica super-micro de neutralização de anticorpos (Ac) anti-estreptolisina O (ASLO) foram padronizadas. Na segunda etapa, foram identificadas as bandas de antígenos celulares e extracelulares reconhecidas por 56 soros de pacientes com febre reumática (Grupo A), 91 soros de indivídos sem diagnóstico de sequelas não-supurativas da infecção, mas com títulos baixos, médios e altos de Ac ASLO (Grupo B), e 41 soros de crianças sem infecção (Grupo C). Em pacientes com febre reumática, Acs IgG e IgA foram detectados, mas Acs IgM não foram encontrados. Anticorpos IgG de pacientes do grupo A reconheceram um total de 30 bandas do antígeno celular, sendo específicas 18 (14, 17, 19,22,23,28,29,32,36, 73, 83, 102, 104, 108, 11 0, 116, 118 e 125 kDa). O resto das 12 bandas foram consideradas não específicas por serem reconhecidas por soros do grupo C. Um total de 19 bandas do antígeno extracelular foi reconhecido por Acs IgG do grupo A, sendo apenas 3 bandas (40, 46, 125 kDa) específicas. No grupo C, Acs IgA não foram detectados. Um total de 14 bandas (23, 30, 38, 42, 43, 46, 48, 54, 57, 60, 67, 73, 78 e 116 kDa) do antígeno celular foram identificadas por Acs IgA do grupo A. No antígeno extracelular, 8 bandas (38, 48, 54, 60, 67,\" 73, 78 e 95 kDa) foram reconhecidas por Acs IgA do mesmo grupo. Critério adotado de combinar dados imunoquímicos ou seja, bandas iguais ou maiores que 102 kDa e/ou bandas iguais ou menores que 29 kDa do antígeno celular de S. pyogenes, acrescido da presença de Acs IgA, possibilitaram a discriminação de pacientes com febre reumática e de não infectados, fornecendo máxima sensibilidade, especificidade, eficiência, bem como de valores preditivos de resultados positivo e negativo. Ademais, os achados de Acs IgG contra banda de 28 kDa que está relacionada a antígeno do tecido cardíaco, um dos 6 perfís imunoquímicos fornecidos por antígeno celular e Acs IgG do presente estudo, e a presença de Acs IgA parecem constituir sinais precoces associados à patogênese da febre reumática. Desta forma no grupo B, 9 pacientes revelaram a banda de 23 kDa do antígeno celular, destes 7 apresentaram perfis compatíveis com os do grupo A, sendo que apenas 1 deles não apresentou Acs IgA. Os dados sugerem que estes pacientes tendem a evoluir para a forma sintomática da febre reumática, requerendo acompanhamento clínico e laboratorial cuidadoso. / The rheumatic fever is one of the sequelae from the Streptococcus pyogenes infection, affecting manly children and young persons, with high rates of morbidity and mortality in many regions of the world. Immunological profiles developed by cellular and extracellular antigens from this bacterium and antibody isotypes found in the patients with rheumatic fever were investigated, due to the scarcity of information about this aspect in the literature. In the first step of this work, conditions to prepare antigens, as well as of techniques, in particular the super-micro technique for the neutralization of antistreptolysin O (ASLO) antibodies (Abs), were standardized. In the second step, bands of cellular and extracellular antigens recognized by 56 serum sera from patients with rheumatic fever (Grupo A), 91 sera from individuals with no diagnosis of supurative sequelae from the infection, but with low, moderate and high ASLO titers (Group B), and 41 sera from children with no infection (Group C) were identified. In patients with rheumatic fever, IgG and IgA antibodies were found, but IgM antibodies were absent. IgG antibodies from rheumatic fever patients recognized 30 bands of the cellular antigens, of these 18 were specific (14,17,19,22,23,28,29,32,36,73,83,102, 104, 108, 110, 116, 118 e 125 kDa). The remaing 12 bands were considered nonspecific because they were recognized by sera from the group C. A total of 19 bands of the extracellular antigen were recognized by IgG Abs from the group A and 3 of these (40, 46 and 125 kDa) were specific. In the group C, no IgA Abs were detected. A total of 14 specific bands (23, 30, 38, 42, 43, 46, 48, 54, 57, 60, 67, 73, 78 and 116 kDa) of the cellular antigen were identified by IgA Abs from the group A. The extracellular antigen had 8 bands (38, 48, 54, 60, 67, 73, 78 and 95 kDa) recognized by IgA Abs from the same group. A criterion adopted of combining immunchemical data, i.e. bands equal or higher than 102 kDa and/or bands equal or lower than 29 kDa of the cellular antigen of S. pyogenes plus the IgA Ab finding, allowed to discriminate rheumatic fever from noninfected individuals, providing maximum sensitivity, specificity, efficiency as well as predictives of positive and negative results. Moreover, the findings of IgG Abs to 23 kDa of the cellular antigen which is associated to the heart tissue antigen, one of those 6 immunochemical profiles provided by cellular antigen and IgG Abs from this study, and the presence of IgA Abs seem to constitute early immunologic signals related to the pathogenesis of the rhematic fever. Thus in the group B, 9 patients revealed a 23 kDa band of cellular antigen, 7 of these showed immunochemical profiIes consistent with those from the group A, and lacking IgA Abs in onIy one of them. The data suggest these patients are prone to deveIop rheumatic fever, requiring a close clinical and laboratory follow-up.

Black Americans experience influenza vaccination rates that are lower than the rates of other ethnic groups. Low influenza vaccination rates among the Black community are associated with higher influenza infection rates, influenza-related hospitalizations, and higher influenza mortality rates. There is a belief within the Black American community that the medical establishment does not have the Black American patient in its best interest, leading to feelings of distrust. The purpose of this study was to determine if the distrust of the medical community is a relevant factor in the low influenza vaccination rates of Black Americans aged 18 and older in Baltimore, Maryland. The study also examined the belief that the influenza vaccine causes the flu and the effect this belief may have on influenza vaccination rates. The public health critical race theory served as the framework for the study. Previously validated survey instruments, the Health Care System Distrust Scale and the Adult Influenza Immunization Survey, were obtained with permission and used to collect data from the members of a Baltimore city church. The study used chi-square analysis, multivariable logistic regression, and narrative discussion to address the research questions and analyze the data of 105 completed surveys. Results of the study determined that distrust of the medical community was not a relevant factor in the influenza vaccination rates of study participants, and that participants' vaccination status was influenced by factors other than distrust. Implications for social change included improving the influenza vaccination rate among Black Americans and decreasing their influenza mortality rates.

Individuals born with primary immune deficiency diseases (PIDD) have a dysfunctional immune system, and many are treated by lifelong injections of immunoglobulin therapy. Studies have shown that these patients have low health-related quality of life (HRQOL) and well-being (WB) and that these outcomes might be improved by the availability of therapy innovated according to preferences for fewer needle sticks or a shorter infusion time. Regulators at the U.S. Food and Drug Administration (FDA) have approved therapies innovated per these preferences. However, there is limited data demonstrating how these innovations impact HRQOL and WB. Using the biopsychosocial model, the purpose of this cross sectional quantitative study was to evaluate whether patients with PIDD using therapies innovated for fewer needle sticks or a shorter infusion time had a higher mean HRQOL and WB compared to those who were not. The study included 153 patients who completed the Patient Reported Outcomes Measurement Information System (PROMIS)-29 survey. The dependent variables were HRQOL and WB measured by PROMIS-29, and the independent variables were the medical product innovations. Independent samples t tests results showed mean PROMIS-29 scores were not statistically different (p > .05). This suggests patients were optimized according to their treatment preference. A subgroup of patients who had taken the PROMIS-29 survey more than once concurrent with switching to a therapy aligned with patient preferences showed improved HRQOL and WB. These findings have implications for positive social change in that seeking the patient's voice to inform medical product innovation and FDA regulatory decision-making has potential to improve biopsychosocial outcomes.

Myeloid-derived suppressor cells (MDSCs) numbers increase significantly in sepsis and are associated with high mortality rates. These myeloid cell precursors promote immunosuppression, especially in the late (post sepsis) stage. However, the mechanisms that underlie MDSC expansion and programming are not completely understood. To investigate these mechanisms, we used a cecal-ligation and puncture (CLP) mouse model of polymicrobial sepsis that progresses from an early/acute proinflammatory phase to a late/chronic immunosuppressive phase. Previous studies in our laboratory showed that microRNA (miR)-21 and miR-181b elevate levels of the transcription factor nuclear factor 1 (NFI-A) that promotes MDSC expansion. We report here that miR-21 and miR-181b regulate NFI-A expression via a post-transcriptional regulatory mechanism by recruiting RNA-binding proteins HuR and Ago1 to stabilize NFI-A mRNA, thus increasing its protein levels. Studies in our laboratory also showed that inflammatory mediator S100A9 accumulates in the nucleus in Gr1+CD11b+ myeloid precursors in the later phases of sepsis and is necessary for their expansion and programming into immunosuppressive MDSCs. We demonstrate here that nuclear S100A9 associates with specific transcription factors that activate miR-21 and miR-181b expressions. In our final manuscript, we uncover another layer of the mechanisms of MDSC expansion and programming. We found that long non-coding RNA (lncRNA) Hotairm1 binds to and recruits S100A9 to the nucleus to program Gr1+CD11b+ myeloid precursors into MDSCs in the later phases of sepsis. Together, our results reveal three regulatory layers involving NFI-A, S100A9 and Hotairm1 in the pathway leading to MDSCs development in sepsis and suggest that therapeutically targeting these molecular switches might improve sepsis survival.

<p>The innate host response to virus infection is largely dominated by the production of type I interferons (IFNs). Fibroblasts, considered nonprofessional immune cells, respond to virus infection after recognition of viral components such as double-stranded (ds)RNA. The constitutively expressed transcription factor IFN regulatory factor 3 (IRF3) is rapidly activated and type I IFNs are produced. In the absence of IRF3, it was found that IFNs are still produced. This thesis identifies IRF9 as the transcription factor responsible for IFN production in the absence of IRF3 based on its ability to bind the murine (m)IFNβ promoter determined via oligonucleotide pull-down assays.</p> <p>In the absence of both IRF3 and IRF9, primary fibroblasts are deficient for IFN signalling. Surprisingly, significant inhibition of virus replication following dsRNA treatment of cells deficient for IRF3 and IFN signalling was recently observed with the large DNA virus herpes simplex virus type 1 (HSV-1) being more susceptible to inhibition than the small RNA virus vesicular stomatitis virus (VSV). As nitric oxide is known for its nonspecific antiviral effects against DNA viruses, involvement of this molecule in the antiviral response to HSV-1 in the absence of IRF3 and type I IFN induction and signalling was investigated. Here it is shown that in the absence of IRF3 and IFN, nitric oxide constitutes a major component of the innate response against HSV-1 in response to dsRNA in primary fibroblasts. In these cells, nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and IRF1 regulate inducible nitric oxide synthase (iNOS) expression, subsequently producing nitric oxide. As most viruses encode strategies to render their environment IRF3 and/or IFN deficient, it appears that IRF9 and nitric oxide serve as secondary responses to protect the host against viral infection. These data emphasize the importance and requirement of the host to employ multiple strategies to overcome infection.</p> / Master of Science (MSc)

<p>Regardless of their origin or pathology, many, if not all, diseases have long been regarded as complex. Yet, despite the progression in the understanding of complexity and the development of systems biology, the majority of biomedical research has been derived from qualitative principles. In comparison to the ethical, temporal and logistical limitations of human experimentation, <em>in vivo</em> animal models have served to provide a more advantageous means to elucidate the underlying disease mechanisms. However, given the additional limitations presented by such models, <em>in silico </em>models have emerged as an effective complement, and, in some cases, a replacement for <em>in vivo</em> experimentation. The <em>in silico </em>models presented in this thesis were developed using mathematical and computational methods to investigate the evolution of two complex, diverse diseases from a systems biology perspective: allergic asthma and cancer.</p> <p>We generated two novel <em>in silico</em> models of allergic asthma aimed at clarifying some dynamic aspects of allergic responses. Experimentally, we utilized an <em>in vivo</em> murine model of chronic exposure to the most pervasive aeroallergen worldwide, house dust mite (HDM), for up to 20 weeks, equivalent to at least 20 human years. Using a range of HDM concentrations, experimental data were collected to study local and systemic effects. The first model applied empirical mathematical techniques to establish equations for airway inflammation and HDM-specific immunoglobulins using an iterative approach of experimentation and validation. Using the equations generated, we showed that the model was able to accurately predict and simulate data. The model also demonstrated the non-linear relationship between HDM exposure and both airway inflammation and allergic sensitization and identified system thresholds.</p> <p>The second model used mechanistic mathematical techniques to investigate the trafficking of eosinophils as they migrated from bone marrow to the blood and, ultimately, to the lungs. Making use of a limited data set, the model determined the effect of individual processes on the system. We identified eosinophil production, survival and death as having the greatest impacts, while migration played a relatively minor role. Furthermore, the model was used to simulate knockout models and the use of antibodies <em>in silico</em>.</p> <p>In the context of cancer growth and metastasis, we developed a theoretical model demonstrating the spatio-temporal development of a tumour in two-dimensions. The model was encoded to create a computer graphic simulation program, which simulated the effects of various parameters on the size and shape of a tumour. Through simulations, we demonstrated the importance of the diffusion process in cancer growth and metastasis.</p> <p>Ultimately, we believe the greatest benefit of each <em>in silico</em> model is the ability to provide an understanding of each respective disease recognized as dynamic and formally complex, but predominantly studied in reductionist, static or un-integrated approaches.</p> / Doctor of Philosophy (Medical Science)

<p>NB: I had another committee member, Dr. Mark Larché; and would like to have his name included in the document.</p> <p>Thank you.</p> / <p><strong>Introduction: </strong>Increasing incidence of chronic immune diseases are mirrored by changing disease risk factors, which include maternal stress during pregnancy. To date, no studies have investigated the impact of prenatal stress challenge (PNS) on the fetal immune system. Fetal liver and bone marrow represent major sources of hematopoietic stem cells (HSC) at mid gestation, which differentiate and mature in the thymus. Disturbance of immune development may cause immune impairment in later life. Further, progesterone is recognized as a critical part of feto-maternal interaction. This study aimed to determine if PNS interferes with normal fetal immune development in mice and the impact of progesterone supplementation on stress effects. <strong>Methods: </strong>DBA/2J-mated BALB/c dams were sorted into three groups: control, PNS (gestation days (GDs) 12.5 and 14.5) and PNS plus progesterone supplementation (DHD). Fetal tissue was collected on GDs 16.5 and 18.5. Flow cytometric analysis examined frequency and phenotype of fetal immune cell populations: HSC in fetal liver and bone marrow, and different stages of T cell maturation and regulatory T (Treg) cells in the thymus. Fetal tails were collected to determine fetal sex by PCR analysis. <strong>Results: </strong>PNS induced a decrease in organ size on GD16.5, which was not seen on GD18.5 and was reversed by DHD treatment. PNS altered the percentage and absolute number of HSC within the liver and bone marrow populations, on GD16.5 and 18.5. There was a significant lag in T cell maturation as demonstrated by the altered expression of CD3 and skewed CD3-:CD3+ ratio. There was a significant decrease in Treg cells within CD3+ thymic cells in response to PNS. PNS effects in the thymus were ameliorated by DHD treatment. There was no PNS-induced sex bias. <strong>Conclusions: </strong>These results indicate that PNS compromises the developing fetal immune system, which could account for impaired immune responses in adults with chronic immune disease, and provide evidence for a therapeutic role of progesterone supplementation.</p> / Master of Science (MSc)

<p>Asthma involves a systemic element that includes the mobilization and lung-accumulation of bone marrow-derived endothelial progenitor cells (EPC). This traffic may be driven by the stromal cell derived factor-1α (SDF-1α)/CXCR4 axis, where SDF1-α is a potent progenitor cell chemoattractant.</p> <p>Interfering with EPC lung-accumulation by administering AMD3100, a CXCR4 antagonist, was previously shown to be associated with the modulation of airway angiogenesis and airway hyperresponsiveness. However, since eosinophils express CXCR4, it is unknown whether AMD3100 acted directly on EPC or indirectly through its anti-inflammatory effects on eosinophils.</p> <p>We investigated the role that eosinophilic inflammation plays in the lung-homing of EPCs and airway angiogenesis in allergic asthmatic response by utilizing eosinophil deficient (PHIL) mice.</p> <p>Wild-type BALB/c (WT) and PHIL mice underwent a chronic house dust mite (HDM) exposure protocol. Treatment groups were administered AMD3100. Outcome measurements were made 24hrs post final exposure and included: flow cytometry to enumerate lung-extracted EPCs, immunostaining for von Willebrand factor to assess bronchial vascularity, bronchoalveolar lavage for airway inflammation, haematoxylin and eosin stain to enumerate eosinophils, picrosirius red stain to assess collagen deposition, and measurement of airway resistance to increasing intranasal doses of methacholine.</p> <p>HDM exposed mice had a significant increase in EPC lung accumulation, bronchial vascularity, airway inflammation, collagen deposition and airway hyperresponsiveness (AHR) in both WT and PHIL groups, with some indices at lower levels in PHIL mice. Concurrent treatment with AMD3100 significantly attenuated EPC lung homing, bronchial vascularity, eosinophil numbers in lung tissue and AHR, but not collagen deposition in WT mice. AMD3100 treatment significantly attenuated all indices in PHIL mice.</p> <p>The findings of this study show that, EPC-driven angiogenesis and the development of AHR in allergic airway responses are independent of eosinophils, the presence of these cells, however, may have a role in worsening of the pathology of allergic airways disease.</p> / Master of Science (MSc)